Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 6.66%127.11B | -3.66%70.26B | -24.76%21.5B | 287.14%160.11B | 457.31%119.18B | 523.22%72.93B | 434.20%28.57B | 12.62%41.36B | -14.62%21.38B | -13.60%11.7B |
| Refunds of taxes and levies | 21.40%491.23M | 13.67%334.99M | 63.62%205.43M | -37.99%567.08M | -45.49%404.65M | -42.22%294.7M | -54.27%125.55M | -42.97%914.49M | -38.77%742.36M | -47.96%510.05M |
| Cash received relating to other operating activities | 664.62%9.13B | 2,502.96%14.93B | 1,044.06%7.18B | -85.04%1.05B | -85.22%1.19B | -93.09%573.76M | -77.53%627.87M | 234.19%7.04B | 375.53%8.08B | 834.64%8.3B |
| Cash inflows from operating activities | 13.21%136.74B | 15.89%85.53B | -1.50%28.88B | 227.99%161.73B | 299.82%120.78B | 259.79%73.8B | 248.38%29.32B | 21.95%49.31B | 8.04%30.21B | 33.09%20.51B |
| Goods services cash paid | 76.25%85.19B | 136.30%55B | 155.02%29.12B | 130.24%72.73B | 106.54%48.33B | 32.17%23.28B | 53.31%11.42B | 39.17%31.59B | 54.71%23.4B | 89.61%17.61B |
| Staff behalf paid | 42.60%4.27B | 51.64%3.12B | 62.24%1.92B | 59.23%3.97B | 65.45%3B | 57.01%2.06B | 50.43%1.18B | 10.02%2.5B | 0.56%1.81B | 7.02%1.31B |
| All taxes paid | 22.89%6.4B | 12.02%3.28B | 0.48%1.33B | 328.76%7.99B | 340.02%5.21B | 216.82%2.93B | 118.19%1.32B | 12.61%1.86B | 68.13%1.18B | 151.46%924.75M |
| Cash paid relating to other operating activities | -58.81%18.22B | -66.77%9.7B | -70.88%4.14B | 683.22%54.51B | 846.92%44.23B | 685.68%29.18B | 715.78%14.21B | -53.53%6.96B | -48.84%4.67B | -11.97%3.71B |
| Cash outflows from operating activities | 13.22%114.09B | 23.77%71.1B | 29.77%36.51B | 224.42%139.21B | 224.34%100.77B | 143.83%57.44B | 165.82%28.14B | 3.15%42.91B | 16.09%31.07B | 56.03%23.56B |
| Net cash flows from operating activities | 13.18%22.65B | -11.76%14.44B | -742.85%-7.63B | 251.93%22.52B | 2,426.95%20.01B | 637.25%16.36B | 154.76%1.19B | 647.49%6.4B | -171.84%-860M | -1,068.03%-3.05B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 499.96%38.69B | 751.57%21.89B | 424.73%10.86B | 55.76%9.73B | 61.00%6.45B | -26.67%2.57B | 2.24%2.07B | --6.25B | --4.01B | --3.5B |
| Cash received from returns on investments | 98.24%126.79M | 258.77%95.69M | 399.69%39.37M | -6.18%75.14M | -11.48%63.96M | -52.32%26.67M | -66.71%7.88M | 648.73%80.09M | 624.67%72.26M | 460.95%55.93M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -62.16%51.79M | -74.38%32.23M | -95.36%5.31M | -51.85%155.12M | -54.07%136.87M | -40.47%125.84M | 43.28%114.58M | -57.03%322.19M | -28.96%298M | 93.52%211.39M |
| Net cash received from disposal of subsidiaries and other business units | --21.69M | ---- | ---- | ---- | ---- | ---- | ---- | 52.76%350M | 92.25%350M | 9.86%200M |
| Cash received relating to other investing activities | --1.2B | --1.2B | 48,202.95%1.2B | 517.71%1.37B | ---- | ---- | --2.49M | -83.66%222.46M | -83.66%222.46M | -83.66%222.46M |
| Cash inflows from investing activities | 502.95%40.1B | 752.77%23.22B | 451.73%12.11B | 56.95%11.33B | 34.39%6.65B | -35.10%2.72B | 3.13%2.19B | 207.22%7.22B | 150.77%4.95B | 152.34%4.19B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -31.75%2.97B | -24.01%2B | -36.80%1.19B | 106.19%7.14B | 87.10%4.36B | 64.78%2.63B | 146.71%1.88B | 2.90%3.46B | -8.41%2.33B | -5.27%1.6B |
| Cash paid to acquire investments | 494.84%44.32B | 484.42%27.37B | 204.06%8.55B | 256.09%20.08B | 274.69%7.45B | 235.08%4.68B | 119.25%2.81B | 116.37%5.64B | --1.99B | --1.4B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --1.25B | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 85.23%1.01B | 46.72%814.98M | 131.13%396.37M | -43.03%621.59M | -28.85%543.82M | 60.70%555.46M | -34.61%171.5M | 105.22%1.09B | -49.04%764.37M | -25.89%345.65M |
| Cash outflows from investing activities | 291.03%48.3B | 230.74%30.18B | 108.37%10.13B | 173.13%27.84B | 143.06%12.35B | 173.10%9.13B | 110.83%4.86B | 56.72%10.19B | 25.70%5.08B | 55.15%3.34B |
| Net cash flows from investing activities | -43.86%-8.2B | -8.79%-6.97B | 174.02%1.98B | -455.34%-16.51B | -4,172.26%-5.7B | -850.59%-6.4B | -1,394.43%-2.67B | 28.44%-2.97B | 93.55%-133.47M | 273.63%853.13M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 821.49%5.2B | 1,000.15%5B | 1,841.75%2B | 856.42%1.52B | 12.75%563.76M | --454.48M | --103M | -97.75%159.24M | -92.93%500M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --1.52B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 11,679.17%8.48B | --8.46B | --7.51B | -98.05%72M | -98.04%72M | ---- | ---- | -13.60%3.7B | 32.69%3.67B | 27.30%2.66B |
| Cash received relating to other financing activities | -43.18%54.41M | -60.75%33.56M | -81.59%13.6M | -33.71%216.24M | -69.90%95.76M | 1,015.22%85.49M | 3,854.77%73.91M | -80.38%326.23M | -71.88%318.13M | -99.31%7.67M |
| Cash inflows from financing activities | 1,776.97%13.73B | 2,398.20%13.49B | 5,281.47%9.52B | -56.74%1.81B | -83.70%731.52M | -79.73%539.97M | -92.16%176.91M | -67.83%4.19B | -59.07%4.49B | -74.05%2.66B |
| Borrowing repayment | 227.10%4.78B | 350.47%3.8B | -28.26%303.54M | -51.94%2.35B | -36.49%1.46B | -17.02%844.57M | 74.19%423.1M | 6.45%4.88B | -34.03%2.3B | -35.55%1.02B |
| Dividend interest payment | 2,689.20%1.69B | 4,084.19%1.65B | -21.33%17.22M | 150.41%609.85M | -60.39%60.41M | -56.35%39.45M | -47.02%21.89M | -11.17%243.54M | -8.81%152.52M | -9.30%90.38M |
| Cash payments relating to other financing activities | -54.19%1.36B | -17.10%172.59M | 15.17%59.86M | 815.58%3.02B | 1,396.77%2.97B | 86.14%208.19M | -14.01%51.97M | -81.96%330.07M | -83.38%198.46M | -90.28%111.85M |
| Cash outflows from financing activities | 74.18%7.82B | 415.28%5.63B | -23.41%380.62M | 9.58%5.98B | 69.45%4.49B | -10.48%1.09B | 44.19%496.96M | -18.45%5.46B | -45.32%2.65B | -56.88%1.22B |
| Net cash flows from financing activities | 257.12%5.91B | 1,523.58%7.86B | 2,955.81%9.14B | -228.34%-4.17B | -304.50%-3.76B | -138.25%-552.24M | -116.74%-320.05M | -120.06%-1.27B | -69.96%1.84B | -80.58%1.44B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -133.68%-2.99M | -110.89%-618.13K | -114.40%-161.79K | 525.97%14.72M | 629.69%8.87M | 74.36%5.68M | 108.98%1.12M | -160.68%-3.46M | -94.40%1.21M | -39.91%3.26M |
| Net increase in cash and cash equivalents | 92.74%20.35B | 62.92%15.33B | 293.52%3.48B | -13.86%1.85B | 1,147.66%10.56B | 1,363.20%9.41B | -303.24%-1.8B | 113.43%2.15B | -83.94%846.28M | -110.26%-744.94M |
| Add:Begin period cash and cash equivalents | 41.39%6.33B | 41.39%6.33B | 41.39%6.33B | 92.48%4.48B | 92.48%4.48B | 92.48%4.48B | 92.48%4.48B | 76.46%2.33B | 76.46%2.33B | 76.46%2.33B |
| End period cash equivalent | 77.44%26.68B | 55.98%21.66B | 266.52%9.82B | 41.39%6.33B | 373.85%15.04B | 777.74%13.89B | 42.43%2.68B | 92.48%4.48B | -51.83%3.17B | -81.56%1.58B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.